Main Article Content Keywords Tapinarof, Aryl Hydrocarbon Receptor Agonist, Remittive Effect, Efficacy, Long-term Therapy, Plaque Psoriasis, Topical References 1. Nowowiejska J, et al. Dermatol Ther (Heidelb). 2022;12:385–406. 2. Langley RGB, et al. Ann Rheum Dis. 2005;64(suppl 2):ii18–23. 3. Bissonnette R, et al. J Am Acad Dermatol. 2021;84:1059–67. 4. Tian D, Lai Y. J Invest Dermatol. 2022;2:100116. https://doi.org/10.1016/j.xjidi.2022.100116. 5. Elmets CA, et al. J Am Acad Dermatol. 2021;84:432–70. 6.